Compounds > poloxalene
Page last updated: 2024-08-22

poloxalene and Injury, Myocardial Reperfusion

poloxalene has been researched along with Injury, Myocardial Reperfusion in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Forman, MB; Murray, JJ; Schaer, GL; Vitola, JV1
Carlson, GC; Farb, A; Kolodgie, FD; Virmani, R; Wilson, PS1
Abrahams, SL; Buddemeier, K; Ennis, B; Hubbell, JP; Hursey, TL; Moy, J; Parrillo, JE; Rodriguez, ER; Schaer, GL1
Austin, GE; Bonner, GD; Farnsworth, WV; Hunter, RL; Justicz, AG; Martino-Saltzman, D; Sink, JD; Soberman, MS; Tuvlin, MB1

Other Studies

4 other study(ies) available for poloxalene and Injury, Myocardial Reperfusion

ArticleYear
Fluosol in myocardial reperfusion injury.
    Journal of the American College of Cardiology, 1995, Volume: 25, Issue:7

    Topics: Animals; Blood Substitutes; Coronary Circulation; Dogs; Fluorocarbons; Myocardial Reperfusion Injury; Neutrophils; Poloxalene; Rabbits

1995
Hyperoxic reperfusion is required to reduce infarct size after intravenous therapy with perfluorochemical (Fluosol-DA 20%) or its detergent component (poloxamer 188) in a poorly collateralized animal model. Absence of a role of polymorphonuclear leukocyte
    Journal of the American College of Cardiology, 1994, Volume: 24, Issue:4

    Topics: Animals; Collateral Circulation; Coronary Circulation; Detergents; Drug Combinations; Fluorocarbons; Hydroxyethyl Starch Derivatives; Infusions, Intravenous; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Oxygen; Peroxidase; Poloxalene; Rabbits

1994
Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function.
    Circulation, 1994, Volume: 90, Issue:6

    Topics: Animals; Chemotaxis, Leukocyte; Collateral Circulation; Coronary Circulation; Coronary Disease; Dogs; Gases; Heart; Infusions, Intravenous; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Necrosis; Neutrophils; Poloxalene; Ventricular Fibrillation; Ventricular Function, Left

1994
Reduction of myocardial infarct size by poloxamer 188 and mannitol in a canine model.
    American heart journal, 1991, Volume: 122, Issue:3 Pt 1

    Topics: Animals; Coronary Circulation; Dogs; Drug Therapy, Combination; Mannitol; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Poloxalene

1991